Market Closed -
Nyse
04:00:01 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
10.7
USD
|
+1.23%
|
|
+14.19%
|
-5.14%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,979
|
1,786
|
1,767
|
1,836
|
1,759
|
1,664
|
-
|
Enterprise Value (EV)
1 |
1,979
|
1,786
|
1,767
|
1,836
|
1,759
|
1,664
|
1,664
|
P/E ratio
|
21.3
x
|
19.4
x
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.04
x
|
0.89
x
|
1.45
x
|
1.27
x
|
1.23
x
|
1.17
x
|
1.13
x
|
EV / Revenue
|
1.04
x
|
0.89
x
|
1.45
x
|
1.27
x
|
1.23
x
|
1.17
x
|
1.13
x
|
EV / EBITDA
|
7.63
x
|
5.36
x
|
5.05
x
|
5.21
x
|
4.84
x
|
4.43
x
|
4.23
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
147,790
|
153,293
|
153,959
|
154,796
|
155,933
|
157,419
|
-
|
Reference price
2 |
13.39
|
11.65
|
11.48
|
11.86
|
11.28
|
10.57
|
10.57
|
Announcement Date
|
2/28/20
|
2/25/21
|
3/1/22
|
2/15/23
|
2/13/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,904
|
2,003
|
1,221
|
1,441
|
1,424
|
1,426
|
1,479
|
EBITDA
1 |
259.4
|
333.4
|
349.9
|
352.2
|
363.2
|
375.4
|
393.5
|
EBIT
1 |
231.1
|
245.1
|
320.4
|
339
|
328
|
365.6
|
387.5
|
Operating Margin
|
12.14%
|
12.24%
|
26.25%
|
23.53%
|
23.03%
|
25.63%
|
26.2%
|
Earnings before Tax (EBT)
|
133.8
|
134.7
|
-
|
-
|
-
|
-
|
-
|
Net income
|
101
|
92.94
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
5.3%
|
4.64%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.6300
|
0.6000
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/20
|
2/25/21
|
3/1/22
|
2/15/23
|
2/13/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
313.7
|
312
|
387.2
|
378
|
363.8
|
334.1
|
365.7
|
364.1
|
360.4
|
324.6
|
362.9
|
365.7
|
373
|
EBITDA
1 |
84.3
|
77.07
|
95.13
|
87.28
|
92.71
|
78.05
|
94.12
|
94.93
|
96.04
|
82.75
|
95.2
|
97.4
|
100
|
EBIT
1 |
68.56
|
75.13
|
90.71
|
83.9
|
89.27
|
74.3
|
71.64
|
90.5
|
91.59
|
77.78
|
93.6
|
95.8
|
98.4
|
Operating Margin
|
21.86%
|
24.08%
|
23.43%
|
22.2%
|
24.54%
|
22.23%
|
19.59%
|
24.86%
|
25.42%
|
23.96%
|
25.79%
|
26.2%
|
26.38%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/22
|
5/10/22
|
8/4/22
|
11/1/22
|
2/15/23
|
5/8/23
|
8/3/23
|
11/1/23
|
2/13/24
|
5/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/20
|
2/25/21
|
3/1/22
|
2/15/23
|
2/13/24
|
-
|
-
|
Last Close Price
10.57
USD Average target price
15.5
USD Spread / Average Target +46.64% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.14% | 1.66B | | +4.60% | 66.76B | | +3.32% | 19.96B | | +7.38% | 5.38B | | +63.62% | 2.06B | | +1.02% | 1.86B | | -19.79% | 1.31B | | 0.00% | 656M | | +28.04% | 584M | | -14.82% | 454M |
Other Tobacco
|